RxDoctor Payments Data

Laura Stampleman

Hematology & Oncology · Monterey, CANPI 1528065810

Payments from drug & device makers

$268,800in general payments, 2019–2025

Across 92 payments — averaging $2921.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$139K
  • Daiichi Sankyo Inc.$68K
  • Eli Lilly$43K
  • E.r. Squibb & Sons, L.L.C.$9K
  • TG Therapeutics, Inc.$3K
  • Bristol Myers Squibb$3K
  • plus $4K from 2 others
$5,129in research payments, 2019–2025

Across 3 payments — averaging $1709.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$5K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$268,800 in reported general payments places this provider in the 80th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Other hematology & oncology in Monterey

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →